ArticleBiometrics2025
Estimating heterogeneous treatment effects for general responses.
Article in Biometrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Heterogeneous treatment effect estimation for observational data using model-based forests.Statistical methods in medical research · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Heterogeneous treatment effect models allow us to compare treatments at subgroup levels and are becoming increasingly popular in applications such as personalized medicine, advertising, and education. Regardless of the type of responses (continuous, binary, count, survival), most causal estimands focus on the differences between the treatment and control conditional means. In this paper, we propose an alternative estimand, DINA-the DIfference in NAtural parameters-to quantify heterogeneous treatment effects motivated by exponential families and the Cox model. Despite the type of responses, DINA is both convenient and more practical for modeling the influence of covariates on the treatment effect. Additionally, we introduce a meta-algorithm for DINA, enabling practitioners to utilize powerful off-the-shelf machine learning tools for the estimation of nuisance functions. This meta-algorithm is also statistically robust to errors in the nuisance function estimation. We demonstrate the efficacy of our method in combination with various machine learning base-learners on both simulated and real datasets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.